Invention Grant
- Patent Title: P2X7R antagonists and their use
- Patent Title (中): P2X7R拮抗剂及其用途
-
Application No.: US13556988Application Date: 2012-07-24
-
Publication No.: US08815892B2Publication Date: 2014-08-26
- Inventor: Michael Bös
- Applicant: Michael Bös
- Applicant Address: DE Martinsried
- Assignee: Affectis Pharmaceuticals AG
- Current Assignee: Affectis Pharmaceuticals AG
- Current Assignee Address: DE Martinsried
- Agency: Christensen O'Connor Johnson Kindness PLLC
- Priority: EP08005532 20080325
- Main IPC: A61K31/44
- IPC: A61K31/44
Abstract:
The present application is directed to novel P2X7R antagonists that are indol-3-carboxamide or azaindole-3-carboxamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.
Public/Granted literature
- US20130197046A1 NOVEL P2X7R ANTAGONISTS AND THEIR USE Public/Granted day:2013-08-01
Information query
